BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

BIOORG MED CHEM LETT

ISSN / eISSN

0960-894X / 1464-3405

Aims and Scope

Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.

Subject Area

CHEMISTRY, ORGANIC

CHEMISTRY, MEDICINAL

CiteScore

5.50

View Trend

CiteScore Ranking

Category	Quartile	Rank
Chemistry - Organic Chemistry	Q2	#70/197
Chemistry - Pharmaceutical Science	Q2	#64/171
Chemistry - Clinical Biochemistry	Q2	#52/113
Chemistry - Drug Discovery	Q2	#75/156
Chemistry - Biochemistry	Q2	#209/428
Chemistry - Molecular Medicine	Q3	#94/171
Chemistry - Molecular Biology	Q3	#217/380

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
CHEMISTRY, MEDICINAL - SCIE	Q3
CHEMISTRY, ORGANIC - SCIE	Q2

H-index

133

Country/Area of Publication

ENGLAND

Publisher

Elsevier Ltd

Publication Frequency

Semimonthly

Year Publication Started

1991

Annual Article Volume

372

Open Access

Contact

PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB

Popular journals in the same field
Recent articles

Identification of benzothiazoles as novel PCSK9 inhibitors: (2023) Zhixin Ma, Hongtao Liu, Shan Jiang, Wenya Li, Yue Li, Yiting Liu, Li Wang, Wenyan Li

Corrigendum to “Cytotoxicity, anti-tumor effects and structure–activity relationships of nickel and palladium S,C,S pincer complexes against double and triple-positive and triple-negative breast cancer (TNBC) cells” [Bioorg. Med. Chem. Lett. 43(2021)128107]: (2023) Mahboubeh Hosseini-Kharat, Rahmatollah Rahimi, Ali Mohammad Alizadeh, Davit Zargarian, Solmaz Khalighfard, Loïc P Mangin, Nasim Mahigir, Seyed Hasan A...

Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach: (2023) Yudai Imai, Ryo Suzuki, Daisuke Matsuda, Nozomi Tanaka-Yamamoto, Yuta Ohki, Ryotaro Tabata, Sota Kato, Mami Sugisaki, Natsuko Fujimoto, Takuya Fukunag...

Synthesis, anti-inflammatory activity, and conformational relationship studies of chromone derivatives incorporating amide groups: (2023) Tao Xing, Shuyan Yu, Meng Qin, Mengdi Zhang, Yuheng Ma, Zhibin Xiao

Direct evaluation of polarity of the ligand binding pocket in retinoid X receptor using a fluorescent solvatochromic agonist: (2023) Kizuku Miura, Michiko Fujihara, Masaki Watanabe, Yuta Takamura, Mayu Kawasaki, Shogo Nakano, Hiroki Kakuta

Virtual screening for early identification of potent and selective histone deacetylase 6 inhibitor series: (2023) Shawn J. Stachel, Deping Wang, Anthony T. Ginnetti, Shahriar Niroomand, Lei Ma, YingHui Hu, John F. Fay, Wei Lemaire, Daniel J. Krosky, Andres D. Rami...

Design and synthesis of indol-2-one derivatives as potential RET inhibitors: (2023) Zhenzhu Li, Kai Sun, Yuanhong Xu, Fuli Zhu, Zhenyu Mao, Yang Wang, Yaxia Yuan, Ting Qiu, Xiabin Chen, Lei Ma

2,5-Dihydroxyacetophenone attenuates RANKL-mediated osteoclastogenesis by affecting the NFATc1 signaling pathway in vitro: (2023) Hai-Wei Chen, Chi-Fen Chen, Pei-Rong Lee, Shuenn-Jium Yiin, Jia-Yun Liang, Jue-Liang Hsu, Chi-I Chang, Chi-Liang Chern

Development of truncated Battacin antimicrobials featuring novel N-terminal fatty acids with an excellent safety profile: (2023) Luka Posa, Petr Tomek, Saurabh Lamba, Vijayalekshmi Sarojini, David Barker

Design, Synthesis, and Evaluation of 18F-Labeling CYP1B1 PET Tracer Based on 2-Phenylquinazolin: (2023) Jiajing Cai, Lan Yi, Zhu Xia, Xinyue Huang, Meixian Yang, Zhenghuan Zhao, Chenyang Gao, Hengyi Yang, Jiayuan Zhang, Zhiping Peng, Dachuan Qiu

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

2021.11.25. submit - Submitted on November 25, 2021.
2022.1.15. revision - Revision on January 15, 2022.
2022.2.14. accepted - Accepted on February 14, 2022.

2022-02-15

Already voted but don't know the outcome yet.

2021-10-11

View All Reviews

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now